Purchase Order VA25617P0131
- Not listed
- The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price purchase order to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of pharmaceuticals. The $698,075.00 contract does not have a set-aside designation and was completed on June 3, 2019. Tri-Pharma, a specialty pharmaceutical wholesaler, has provided various pharmaceutical products and medical supplies to the VA and Department of Health and Human Services under previous...
- This federal contract award to Tri-Pharma, Inc. (doing business as Tri-Pharma Inc.) was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The $123,374.00 firm-fixed-price purchase order, which has no set-aside designation, is for IV solutions. The contract supports the Hurricane Harvey 2017 National Interest Action. Tri-Pharma is a minority-owned, self-certified small disadvantaged business that specializes in sourcing and...
- This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs Veterans Health Administration to Tri-Pharma, Inc., a minority-owned small disadvantaged business, for the delivery of pharmaceuticals. The contract has a potential value of $698,075.00 and a completion date of June 3, 2019. Tri-Pharma has previously provided pharmaceutical products and personal protective equipment to various government agencies, including the VA and the Department of Health and Human...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract has a ceiling value of $46,544.00 and a period of performance through June 27, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 29, 2025 and a ceiling value of $27,926.40. The contract is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,925.84 Firm Fixed Price Delivery Order covers the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product, with a period of performance through December 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation. The order is for the pharmaceutical product GAMUNEX-C 1 GRAM/10 ML VIAL 10ML, with a ceiling value of $2,404.40 and a performance period through April 26, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA Troop Support Medical,...
- This is a $57,708.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of GAMUNEX-C 40 gram/400 ml vials, with an ultimate completion date of May 20, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a...
- This is a $148,545.00 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Core Trading Co, a minority-owned, veteran-owned, and service-disabled veteran-owned small business located in Chesapeake, Virginia. The contract is for the procurement of "EMERGENCY GAMUNEX" and does not have a set-aside designation. The contract has an ultimate completion date of May 1, 2017. Core Trading Co has a robust history of providing a wide range of pharmaceutical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024. The $3,061.60 firm fixed-price delivery order contract is for the supply of GAMUNEX-C 5 gram/50 ml vials, a specialty pharmaceutical product, with a completion date of December 6, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Tri-Pharma, Inc., a minority-owned, small disadvantaged business, for the supply of GAMUNEX-C 10% 20GRAM/2MML VIAL. The contract has a ceiling value of $230,000.00 and an ultimate completion date of June 5, 2017. The contract is not designated as a set-aside. Tri-Pharma, Inc. is a Subchapter S Corporation that specializes in providing pharmaceuticals, personal protective equipment (PPE), and medical supplies to various federal government agencies, including the VA, Department of Health and Human Services, and Department of the Army. In addition to this purchase order, Tri-Pharma holds a single-award Blanket Purchase Agreement (BPA) with the Department of the Army Installation Management Command Northeast Region, valued at up to $250,000, for the delivery of PPE and cleaning supplies to support COVID-19 pandemic response efforts and routine maintenance at Army facilities in the Northeast region.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $230.0k | 11/4/16 |